It is generally believed that blocking the VEGF-VEGFR signalling would augment compensatory mechanisms of tumour angiogenesis by elevating expression levels of angiogenic factors that these drugs do not target, circumventing the VEGF-dependent angiogenic signals2, 19, 20, 21, 22. Here, VEGFA is linked to neoplasm.